logo
Share SHARE
FONT-SIZE Plus   Neg

Keryx Says Perifosine X-PECT Phase 3 Trial Failed To Meet Primary Goal

Keryx Biopharmaceuticals, Inc. (KERX: Quote) said the Phase 3 "X-PECT", or Xeloda + Perifosine Evaluation in Colorectal cancer Treatment, clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer failed to achieve the primary endpoint of improving overall survival versus capecitabine + placebo.

The company noted that 468 patients at sixty-five U.S. sites participated in the study.

Ron Bentsur, Chief Executive Officer of Keryx, stated, "We are all extremely disappointed with the results of the study...We will evaluate whether our Phase 3 study of Perifosine in relapsed/refractory multiple myeloma will continue as planned.

With approximately $31 million in cash as of March 31, 2012, and a well-controlled burn rate, we plan to focus our resources on the pending completion of the Zerenex (ferric citrate) long-term Phase 3 study for end stage renal disease (ESRD) patients with hyperphosphatemia, expected in the fourth quarter of 2012, and the New Drug Application (NDA) filing for Zerenex which will hopefully follow shortly thereafter."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Mixed signal solutions provider NXP Semiconductors N.V. (NXPI) agreed Sunday to acquire embedded processing solutions provider Freescale Semiconductor Ltd (FSL) in a cash an stock deal valued at about $16.7 billion, including Freescale's net debt of $4.9 billion. Get ahead of the market. For in-depth... Mitel Networks Corp. (MITL, MNW.TO) and Mavenir Systems (MVNR) announced a merger agreement in which Mitel will acquire all of the outstanding shares of Mavenir common stock in a cash and stock deal valued at approximately $560 million. Get ahead of the market. For in-depth analysis not... ISIS has renewed its death threat to employees of micro-blogging site Twitter, Inc., particularly its co-founder Jack Dorsey. The threats are in retaliation for Twitter blocking accounts which are affiliated to or support the Islamic State. Twitter has a policy of barring users from posting threats or using the service for furthering of illegal activities.
comments powered by Disqus
RELATED NEWS
Trade KERX now with 
Follow RTT